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ABSTRACT 
Background The incorporation of Human papillomavirus (HPV) testing into the 
English cervical screening programme has been met with fear and anxiety. Healthcare 
professionals need to be adequately informed about HPV to help alleviate patient 
concerns.  
The aim of this study was to evaluate the HPV training provided to practice nurses 
(PN) and determine their level of HPV knowledge. 
 Method A web-based survey was distributed to 147 General Practice surgeries in the 
Leicester, Leicestershire & Rutland regions, between May-July 2015. The survey 
explored four broad areas; demographics/level of experience, HPV knowledge, 
attitudes towards the HPV vaccine and self-perceived adequacy of HPV knowledge. 
Results 128 surveys were completed, with 94 complete responses. Overall awareness 
of basic HPV facts was adequate, however detailed and in some basic knowledge was 
lacking. 9.6% failed to identify that HPV can cause cervical cancer and 62.8% 
believed that HPV requires treatment. Not all PN felt adequately informed about HPV 
and a need to improve the provision of training was identified. 
Conclusion PN play a key role in increasing public awareness of HPV and 
implementing cervical cancer screening. The provision of education to PN needs to be 
a priority and current methods of training need to be re-evaluated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Since Professor Zur Hausen first identified the role of human papillomavirus (HPV) 
in the development of cervical cancer over 3 decades ago1, 2, knowledge of the 
relationship between the two has increased multi-fold. It is now known that HPV is 
implicated as a causative factor in 99.7% of all cervical cancers3 and as a consequence 
HPV has been incorporated into both primary and secondary cervical cancer 
prevention strategies. 
The introduction of prophylactic vaccines against high-risk HPV represents the first 
step in reducing disease burden. The two most widely used HPV vaccines globally are 
the bivalent and the quadrivalent vaccines4, which provide protection against the 
high-risk HPV types 16 and 18, reported to account for 70% of all cervical cancers5. 
In areas of high vaccine uptake the benefits are already evident with decreases in the 
incidence of high-grade cervical abnormalities and the prevalence of vaccine HPV 
types6.  
HPV testing is also pivotal in secondary prevention in the form of HPV triage and test 
of cure (TOC), which were introduced into the English Cervical Screening 
Programme (CSP) in 20117. The use of HPV testing to triage low-grade cytological 
abnormalities has been shown to be more sensitive for earlier detection of cervical 
intraepithelial neoplasia grade (CIN) II+, compared to standard liquid based cytology 
alone8. Furthermore it permits earlier return to routine recall in those with mild 
cytological abnormalities who are negative for high-risk HPV; and similarly for those 
testing negative post treatment, follow-up is considerably shortened9. 
 
Despite the benefits, the integration of HPV into the CSP in England has posed many 
challenges for healthcare professionals. Firstly there was a need to update the 
provision of training to ensure effective dissemination of the new protocol, in addition 
to providing HPV-related education. Previous studies have demonstrated that HPV 
knowledge amongst healthcare professionals is variable and in some even deficient10-
15. Secondly there is the challenge of communicating these substantial changes to the 
women in a clear and non-judgemental manner. Evidence thus far has shown that 
service users have met this new protocol with anxiety, confusion and embarrassment 
due to the stigma associated with HPV16.  
 
In England practice nurses (PN), perform the majority of cervical smears and will 
often represent the first and only point of contact women have with the CSP. 
Consequently it is essential that PN are adequately informed about the new screening 
protocol and are able to convey information to women, regarding HPV, its role in 
cervical cancer aetiology and its natural history, without creating anxiety or 
confusion. 
With the introduction of HPV triage and TOC in England, the National Health 
Service (NHS) CSP developed a HPV training package for all cervical smear sample 
takers. This consisted of an information pack that was sent out to all General Practice 
surgeries included in this study in February 2012 and incorporation of HPV education 
into the 3 yearly updates, which are recommended by the NHS CSP for nurses or one 
off face to face HPV-specific training sessions. Training could be undertaken face to 
face or via an internal general practice “cascade” system.   The aim of this study was 
to evaluate the effectiveness of current HPV training and to determine the level of 
HPV knowledge in PN cervical smear sample takers. 
 
METHODS 
An anonymous cross sectional survey was conducted between May-July 2015 to 
evaluate our aims. The web-based survey was distributed via a regional mailing list to 
147 General Practice surgeries in the Leicester, Leicestershire and Rutland area, in the 
UK. The practice managers were asked to cascade the survey to all registered PN 
cervical smear takers working within their surgery.  There were a total of 479 PN 
cervical smear takers registered for this area. Two reminder emails were sent during 
the study period and a built in mechanism in the online survey tool “smart survey” 
prevented double entries. 
 
Survey development  
Following an extensive literature search, the authors (HP, KAS), in collaboration with 
the local screening co-ordinator from Public Health England, developed the survey. 
The NHS CSP HPV training package was used as a guide from which to develop and 
set standards for the questions. Pre-existing validated HPV knowledge questions were 
incorporated into the survey where appropriate17. This survey tool has been 
previously used to assess the level of HPV knowledge in the lay population and 
therefore it was felt that this is the minimal level of knowledge that healthcare 
professionals should have. The survey was pre-tested on a convenience sample of 15 
PN from outside the study area for content validity and relevance. It was estimated 
that the survey would take approximately 10 minutes to complete. 
The final 12-point survey explored four broad categories: demographics and level of 
experience, HPV knowledge (general HPV knowledge, HPV triage/TOC knowledge, 
HPV vaccine knowledge), attitudes towards the HPV vaccine and self-perceived 
adequacy of HPV knowledge. The knowledge questions were assessed using a “select 
all that apply” format and 5-point Likert scales were used to measure attitudes and 
perceptions. 
 
Data analysis 
Statistical analysis was performed using Statistical Package for Social Sciences, IL, 
USA, version 22. Descriptive statistics were generated for the responses and 
correlation co-efficients to describe relationships between two continuous variables.  
For independent samples the Chi square and Kruskal-Wallis test were used to 
compare categorical and continuous variables, as the data was non-normally 
distributed. P-values of 0.05 or less were considered to be significant. Free text was 
analysed using NVivo qualitative research software, examining for common themes. 
This study was performed in accordance with the local clinical governance, audit and 
service evaluation guidelines. 
  
RESULTS 
A total of 128 PN completed the online survey. Of these 94 were complete responses. 
Only the complete responses were used for data analysis. The age of the respondents 
ranged from 27 to 61years (median 50years) and all the PN were females. The median 
number of years that the PN had been performing cervical smears was 10.5 years 
(range <1 to 36 years). The majority of the PN (53.2%, n=50) last attended a HPV 
training session more than 12 months ago and 3.2% (n=3) had never attended despite 
the fact they have been performing cervical smears for between 2 to12 years (Table 
1). 
 
General HPV knowledge 
Out of a maximum knowledge score of fifteen, the median score achieved by the 
participants was 13(range 7-15). All of the PN answered more than 50% of the 
questions correctly and furthermore 83% (n=78) correctly answered 80% or more. 
Confusion existed regarding the need for treatment for HPV; with only 37.2% (n=35) 
correctly identifying that HPV does not require any treatment. There was greater 
appreciation for the association between HPV and cervical cancer than that between 
HPV and genital warts (p=0.03). However, 9.6% (n=9) failed to recognise that HPV 
can cause cervical cancer and of these 3.2% (n=3) were not aware of either of the two 
associations (Table 2). 
 
HPV triage and TOC knowledge 
Overall PN had a sound understanding of the HPV triage and TOC pathways, 
achieving a median score of 9 (range 5-10) out of 10. However, some uncertainty 
existed concerning the timing of the HPV test and its interpretation; 17% (n=16) did 
not believe that the HPV test could be done at the same time as the smear test and 
22.3% (n=21) failed to accept that if a woman does not have HPV then her risk of 
developing cervical cancer is low. Moreover the role of HPV testing post-treatment 
(TOC) was misinterpreted, with only 66% (n=62) acknowledging that all normal, 
borderline nuclear and mildly dyskaryotic samples are tested for high risk HPV post-
treatment and 8.5% (n=8) believed that annual follow for ten years was still required 
despite a negative TOC result. (Table 2) 
 
HPV vaccine knowledge 
This section was scored out of 7; the participants achieved a median score of 6 (range 
4-7), with responses from three participants missing. Although the overall HPV 
vaccine knowledge score was good, detailed knowledge appeared to be lacking: 
37.2% (n=35) were not aware that the vaccine protects against most cervical cancers 
and only 60.6%(n=57) knew that one of the vaccines provides protection against 
genital warts. However, importantly all correctly acknowledged the need for 
continued cervical screening post-vaccination. (Table 2) 	  
Factors influencing level of HPV knowledge 
PN age and the number of years of experience did not correlate with HPV knowledge 
in any of the three tested knowledge categories (Table 3). Timing of the last HPV 
training session also did not have a significant influence on knowledge scores, and 
even those who had never attended a HPV training session achieved comparable 
knowledge scores (Table 4).  
 
Attitudes towards HPV vaccine 
Almost all the PN (98.9%, n= 93) either strongly agreed or agreed that they would 
recommend the HPV vaccine and 88% (n= 83) felt that the vaccine should be offered 
to boys as well. Those who were undecided or disagreed with boys being offered the 
HPV vaccine had a significantly lower overall general HPV knowledge score 
compared to those who agreed/strongly agreed (p=0.02). 
 
Self-perceived adequacy of HPV knowledge  
Only 68% (n=64) stated that they felt adequately informed about HPV with the rest 
undecided, disagreeing or strongly disagreeing (19.1% (n=18), 10.6% (n=10), 2.1% 
(n=2)). However, 33% of those who did not feel adequately informed still felt that 
they were confidently able to answer all questions asked by service users.  
The HPV knowledge scores did not significantly vary between self-perceived 
awareness of HPV or ability to answer questions posed by women.  
 
Improving training 
It emerged from the free text that PN felt that the delivery of HPV training could be 
improved. They expressed that there was a requirement for continued HPV education, 
with the provision of regular updates. It was proposed by some that this could be 
achieved with the use of emails or newsletters featuring salient HPV facts along with 
notification of new developments. The most popular recommendation was for the 
development of an online training programme, with an assessment component and 
commonly asked questions by women. It was believed that online resources would be 
easier to access and therefore likely to increase participation. Key barriers to attending 
educational meetings were stated as travel distance and lack of time in which to 
attend.	   
 
DISCUSSION 
Main findings of this study 
The results of this study support that PN overall, have adequate levels of HPV 
knowledge. On average they correctly answered 86% of the knowledge-based 
questions across the three categories. It was however, evident that key basic facts 
were missed by some; 9.6% failed to identify that HPV can cause cervical cancer and 
over 30% did not recognise sexual intercourse at an early age as a risk factor or that 
most sexually active women will acquire HPV. It has been shown that simply 
informing women that HPV is common can help reassure them18. The most poorly 
answered question was regarding the treatment of HPV, a majority of 62.8% 
erroneously stated that HPV requires treatment. Furthermore detailed awareness 
across all three HPV knowledge categories was lacking. Just over a fifth were 
unaware that HPV could be passed on by genital skin to skin contact or that it is 
responsible for genital warts and confusion existed regarding the role of TOC and the 
impact it has on follow-up post-treatment. PN lacked up-to-date HPV vaccine 
information, 24.5% were not aware of the new two dose vaccine schedule19 and 
35.1% did not know of the added protection provided by the quadrivalent vaccine 
against genital warts. The quadrivalent vaccine has been in use in England since 
September 2012. This is likely to be reflective of the fact that the majority of PN in 
our cohort had not attended a HPV training session for over 12 months.  
Clinical experience did not correlate with increased HPV knowledge, it may be 
inferred from this finding that clinical experience alone is not adequate to obtain 
sufficient awareness of HPV and that there is a requirement for formal HPV 
education. 
It emerged that PN felt that the provision of HPV training needed to be improved. The 
majority of the respondents stated that the development of an online e-learning 
programme could be a way of achieving this. 
 
What is already known on this topic 
There is abundant research demonstrating poor awareness of HPV amongst different 
groups within the lay population20-23. Evaluation of HPV knowledge in physicians, 
from across the globe, in countries with differing cervical screening programmes, has 
shown that knowledge levels are variable and may differ between specialities 24-28.  
In the England, PN have not previously been investigated but HPV knowledge in 
other groups of healthcare professionals (General Practitioners, Paediatricians and 
Obstetricians and Gynaecologists) has been shown to be low29. In New Zealand and 
Ireland where the majority of cervical smears are performed in primary care, studies 
exploring awareness of HPV in PN, have also found that detailed HPV knowledge 
was deficient30, 31. PN and General Practitioners were unclear on the role of HPV 
testing and how it is done31. Level of HPV knowledge in school nurses, who are 
responsible for the administration of the HPV vaccine in many countries32,  is also 
variable15, 33-35. HPV knowledge in nurses has been identified as an important 
precursor for a positive attitude towards the vaccine33, 36. 
 It is acknowledged that there are challenges of communicating HPV related 
information to women37 and healthcare providers have self-reported feeling 
uncomfortable answering HPV-related questions38. The exact reasons for this have 
not been established but one may argue that this is reflective of their own lack of HPV 
awareness, given the results of the previously mentioned HPV knowledge studies in 
this group. 
The provision of education to women has been shown to be key in increasing 
knowledge of HPV, cervical cancer and significantly decreasing concerns about 
receiving a positive HPV test result39. In addition the value of participation with 
cervical cancer screening, in women, is positively associated with education40. 
The content and the quality of the information shared needs to be accurate and clear to 
avoid misunderstandings16. Patients have erroneously believed that HPV testing is a 
test of fidelity41.  
These findings emphasise the central role of HPV education in the uptake of 
preventative health measures. 
 
With regards to improving HPV education, the use of e-learning within medical 
education is increasing and it has been shown to be a useful adjunct to traditional 
teaching methods42.  PN identified lack of time and travelling distance as barriers to 
attending training sessions. One of the benefits of e-learning is that it permits learner 
centred education which transcends geographical boundaries43 and therefore is likely 
to result in increased participation.  Previous studies that have explored the role of 
web based continued medical education in the context of cervical cancer screening 
have shown favourable results, particularly in terms of increasing knowledge levels 
and enhancing the adoption of clinical guidelines44. 
 
What this study adds 
The changes in the CSP, which have resulted from the implementation of HPV 
testing, have had a significant psychological impact on women45. Women look to 
healthcare professionals for HPV-related information46 and therefore it is imperative 
that they are able to provide patients with clear,  consistent and accurate information 
to help relieve their anxieties16.  This study highlights the gaps in the basic HPV 
knowledge of PN. They are not adequately informed about HPV and some lack 
familiarity with the new management pathways. Majority of the knowledge questions 
used in this study have previously been used to assess HPV knowledge in the lay 
population20; therefore one may debate that if lay women are accepted to have this 
level of knowledge, knowledge levels in PN should be greater.  The results of this 
study are concerning as PN perform the majority of the 3,500,000 + cervical smears 
performed annually in England47. PN are central to the CSP and are in a powerful 
position to impart knowledge to women. 
 
 
Limitations of this study 
The overall response rate appeared to be low (19.6% for complete responses), 
although it was difficult to accurately determine. The number of PN currently 
working in the region is thought to be below the 479 on the register, since the register 
does not account for nurses who have moved out of area or who are no longer 
practising. An up to date register is vital for ensuring that all PN are adequately 
trained and the lack of one may provide an explanation as to why three PN in our 
cohort had never attended a HPV training session. 
We only sampled one region within England, however PN of varying degrees of 
experience are represented and the guidance on training for cervical cancer screening 
is standardised across the country, although delivery may differ. Therefore we believe 
that our data may be extrapolated to other regions within England but to obtain truly 
representative data the survey would need to be rolled out nationally. Although the 
results of this study are not directly internationally applicable, it provides an insight 
into the challenges of making major changes to a well organised and highly successful 
cervical screening programmes that others can learn from. It draws attention to the 
fact that increased emphasis needs to be placed on the education of healthcare 
professionals, who’s knowledge is often taken for granted. 
Our study revealed that the PN scored highly on the HPV knowledge assessments; 
however there is some debate that the use of online survey tools compared to paper 
versions may result in falsely elevated knowledge scores. It has been argued that 
when using online surveys the participants have access to additional resources, for 
example the internet, which they may use to search for information48. This could 
explain why, despite the PN achieving high knowledge scores, 32% felt inadequately 
informed about HPV and 22% felt that they could not confidently answer HPV-
related questions posed by women.  
 
Cervical cancer prevention is increasingly focusing on HPV and it is likely that in the 
near future primary HPV testing will be the default methodology for cervical cancer 
screening. Consideration needs to be given to re-evaluating the delivery of HPV 
related health education to PN. Training needs to be provided in a more effective and 
efficient manner to ensure that professional understanding it is not lagging behind 
scientific advancements. 
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